At any rate, studies to find protein biomarkers have also been conducted: in 2009, a study confirmed the relationship between diffuse large B cell lymphoma (the most common aggressive type) and the chemokine CXCL13 expression. This evidence concerns the gene CXCL13 and diffuse large B-cell lymphoma.